+654.5%
MRNA vs PAAS
+327.2%
+327.3%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | PAAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -0.7% | -2.9% | -3.4% |
| 7D | -9.0% | +2.0% | -11.0% | -9.5% |
| 30D | +137.2% | -0.1% | +137.2% | +137.3% |
| 3M | +194.8% | +8.2% | +186.6% | +191.0% |
| 6M | +167.2% | -13.8% | +181.0% | +172.2% |
| YTD | +375.9% | -0.6% | +376.5% | +374.1% |
| 1Y | +465.2% | +44.0% | +421.2% | +434.0% |
| 3Y | +30.4% | +246.6% | -216.2% | +7.1% |
| 5Y | -66.8% | +116.1% | -182.9% | -72.0% |
| All | +654.5% | +327.2% | +327.3% | +515.3% |
Cumulative growth
Daily Returns
Daily percentage return beside PAAS.
Daily Out/Under-Performance
Portfolio return minus PAAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PAAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded PAAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling